CD19 and lymphoma: generated CIS‐deleted CB‐derived CD19 CAR NK cells and found CIS KO CAR NK cells showed more significant cytotoxicity against Ramos lymphoma cells and primary chronic lymphocytic leukemia cells than CAR NK cells with wild‐type CIS.